Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Circumscribed choroidal hemangioma and non-pigmented choroidal melanoma: clinical, instrumental and molecular genetic features]. | Vestn Oftalmol | 2024 | 38742493 | PubTator, text mining | PubMed |
| Pathological and Molecular Diagnosis of Uveal Melanoma. | Diagnostics (Basel) | 2024 | 38732371 | PubTator, text mining | PubMed |
| A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. | Cancer Res Commun | 2024 | 38683104 | PubTator, text mining | PubMed |
| Primary leptomeningeal melanocytic neoplasms: A clinicopathologic, immunohistochemical, and molecular study of 12 cases. | Hum Pathol | 2024 | 38670237 | PubTator, text mining | PubMed |
| Sturge-Weber syndrome: an update for the pediatrician. | World J Pediatr | 2024 | 38658498 | PubTator, text mining | PubMed |
| Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients. | Sci Rep | 2024 | 38644411 | PubTator, text mining | PubMed |
| Transcriptome-Based Treatment for Melanoma With Brain Metastasis: A Case Report. | Cureus | 2024 | 38638737 | PubTator, text mining | PubMed |
| The Pediatric and Young Adult Choroidal and Ciliary Body Melanoma Genetic Study, A Survey by the European Ophthalmic Oncology Group. | Invest Ophthalmol Vis Sci | 2024 | 38573618 | PubTator, text mining | PubMed |
| Gα11 deficiency increases fibroblast growth factor 23 levels in a mouse model of familial hypocalciuric hypercalcemia. | JCI Insight | 2024 | 38530370 | PubTator, text mining | PubMed |
| Double somatic mutations in CTNNB1 and GNA11 in an aldosterone-producing adenoma. | Front Endocrinol (Lausanne) | 2024 | 38505749 | PubTator, text mining | PubMed |
| Identification and characterization of a novel CASR mutation causing familial hypocalciuric hypercalcemia. | Front Endocrinol (Lausanne) | 2024 | 38487341 | PubTator, text mining | PubMed |
| Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances. | Int J Mol Sci | 2024 | 38474231 | PubTator, text mining | PubMed |
| Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitors. | Am J Ophthalmol Case Rep | 2024 | 38444640 | PubTator, text mining | PubMed |
| Somatic Loss-of-Function PIK3R1 and Activating Non-hotspot PIK3CA Mutations Associated with Capillary Malformation with Dilated Veins (CMDV). | J Invest Dermatol | 2024 | 38431221 | PubTator, text mining | PubMed |
| PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma. | Oncogenesis | 2024 | 38418838 | PubTator, text mining | PubMed |
| Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations. | Pigment Cell Melanoma Res | 2024 | 38411373 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study. | Invest Ophthalmol Vis Sci | 2024 | 38349785 | PubTator, text mining | PubMed |
| Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants. | Am J Med Genet A | 2024 | 38321651 | PubTator, text mining | PubMed |
| Uveal melanoma: Recent advances in immunotherapy. | World J Clin Oncol | 2024 | 38292657 | PubTator, text mining | PubMed |
| Primary Diffuse Leptomeningeal Melanomatosis in a Child with Extracranial Metastasis: Case Report. | Curr Oncol | 2024 | 38275834 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=9